LibertyStream Aims to Tap Lithium From Permian Basin Produced Water Offering Potential Domestic Supply Alternative Spotify Stock Surges on AI Music Partnership with UMG and Upbeat Guidance ATT CEO Highlights BlueCollar Worker Shortage as AI Reshapes Job Market College Graduates Face New Challenges Wipro Sets June 5 2026 as Record Date for Landmark 15000 Crore Share Buyback HELOC and Home Equity Loan Rates Hold Low in May 2026 but Fed Rate Hike Risks Loom Portugals Meo Sues State for 82 Million Over Huawei 5G Exclusion Intercorp Financial Services Inc IFS Q1 2026 Earnings EPS Surprise Lifts Results Despite Tepid Stock Reaction ATER Q3 2025 Earnings EPS Surpasses Estimates by Over 56 Stock Rises DGXX Q3 2025 Earnings Loss Per Share of 003 as Company Navigates Challenging Environment FTC Solar Q1 2026 Earnings EPS Misses Estimates Amidst Operational Challenges GEG Q1 2026 Earnings Substantial EPS Miss Triggers Stock Decline AII Q1 2026 Earnings Earnings Beat Expectations Amid Strong Underwriting Performance PSQ Holdings Inc PSQH Faces Continued Pressure as Shares Test Key Support Levels Stellus Capital Investment SCM Edges Higher Testing Resistance at 972 Amid Modest Gains Travelzoo TZOO Edges Higher Amidst Renewed Interest Key Levels to Watch Accel Entertainment ACEL Holds Steady Near Support as Trading Volume Remains Subdued Pimco Global StocksPlus Income Fund PGP Edges Higher Amid Stabilizing Price Action BXSL Q1 2026 Earnings Net Investment Income Tops Estimates Shares Edge Higher Turn Therapeutics Inc TTRX Q1 2026 Earnings Narrow EPS Miss Overshadowed by Operational Progress GH Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares Slightly ATLCP Q1 2026 Earnings Preferred Stock Reports Strong EPS Beat AEE Q1 2026 Earnings EPS Beats Estimates by 73 Shares Edge Higher IDEX Q1 2026 Earnings Strong EPS Beat of 117 Surprise Despite Slight Stock Decline Ashiana Housing to Develop Premium Residential Project in Jaipur with Rs 560 Crore Investment ONCY Q3 2025 Earnings Clinical Progress Overshadows WiderThanExpected Loss Rani Therapeutics RANI Plunges Nearly 10 as Stock Tests Critical Support Level